American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
To describe the components of and factors contributing to the costs of inhaled anesthesia, basis for quantifying and comparing these costs, and practical strategies for performing pharmacoeconomic analyses and reducing the costs of inhaled anesthetic agents. ⋯ Understanding factors that contribute to the costs of inhaled anesthesia and considering those factors in pharmacoeconomic analyses and recommendations for use of these agents can result in cost savings.
-
Am J Health Syst Pharm · Apr 2010
Managing inhaled anesthesia: challenges from a health-system pharmacist's perspective.
To discuss the challenges that health-system pharmacists face in managing the use and costs of inhaled anesthesia in the operating room (OR), the characteristics of inhaled anesthesia agents, systems for delivering inhaled anesthesia, and the role of inhaled anesthetics in fast-track recovery after surgery. ⋯ Understanding the differences in characteristics and delivery of the inhaled anesthesia agents will enable health-system pharmacists to collaborate with anesthesia care providers to better manage the use and costs of these agents.
-
Am J Health Syst Pharm · Apr 2010
An anesthesiologist's perspective on inhaled anesthesia decision-making.
To describe the culture and content of anesthesia practice; the stages, types, and goals of anesthesia; nomenclature and factors that can affect dosing of inhaled anesthesia; basis for anesthesiologist choices among inhaled anesthesia agents; and special considerations in using inhaled anesthesia in bariatric surgery patients, pediatric patients, and cardiac surgery patients; and to provide insights into myths associated with inhaled anesthesia. ⋯ Experience and careful consideration of the characteristics of inhaled anesthesia agents and surgery- and patient-specific factors allow anesthesia care providers to meet the rapidly changing needs of patients receiving inhaled anesthesia in a safe and cost-effective manner.
-
Am J Health Syst Pharm · Apr 2010
ReviewBenefits and risks associated with beta-blocker prophylaxis in noncardiac surgery.
The benefits and risks associated with use of beta-blocker prophylaxis in noncardiac surgery (NCS) are described. ⋯ Perioperative use of beta-blockers in NCS can protect against postoperative MI but increases the risk of stroke, severe hypotension, and severe bradycardia. Although less common, the strokes are severe, and the troubling trend toward increasing cardiovascular and total mortality precludes the recommendation for their use in patients not previously treated with beta-blockers.